SPECTRAL GENOMICS
DEAD

Serial Number

76291342

Owner

Spectral Genomics, Inc.

Attorney

Diane L. Gardner

First Use Date

Mar 1, 2001

Filing Date

Jul 26, 2001

Add to watchlist:

No watchlists yet
View on USPTO

SPECTRAL GENOMICS Trademark

Serial Number: 76291342 • Registration: 2890704

SPECTRAL GENOMICS is a trademark filed by Spectral Genomics, Inc. on July 26, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Spectral Genomics, Inc. (7 trademarks)

8080 N. Stadium Drive, Suite 2200
Houston, TX 77054

Entity Type: 03

PERKINELMER LAS, INC. (121 trademarks)

940 WINTER STREET
WALTHAM, MA 02451

Entity Type: 03

PERKINELMER HEALTH SCIENCES, INC. (118 trademarks)

WALTHAM, MA 02451

Entity Type: 03

Trademark Details

Filing Date

July 26, 2001

Registration Date

October 5, 2004

First Use Anywhere

March 1, 2001

First Use in Commerce

March 1, 2001

Published for Opposition

July 13, 2004

Cancellation Date

May 6, 2011

Goods & Services

Scientific measuring apparatus and instruments, namely substrate chips used in the measurement of biopolymers and biological samples; genomic arrays, namely arrays spotted with artificial chromosomes, oligomers, and cDNA clones; arrays, namely arrays of polypeptides, nucleic acids and proteins on substrates for use in genomic analysis; biochips used for genomic hybridization, genomic profiling, DNA copy number estimation, gene duplication and detection, and transcript factor comparisons; computer hardware and software for analyzing images for analysis of biopolymers and biological samples and related user manuals

Pharmaceutical products for clinical and medical use, namely nucleic acid sequences for use in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses; diagnostic medical reagents for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer, comprised of reagents, processing chemicals, and solid matrix materials

Chemical products for scientific and research use, namely, nucleic acid sequences for use in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses

Testing and analysis of biopolymers and biological samples for others; design for others of customized substrate chips used in the measurement of biopolymers and biological samples; design of customized arrays for others; providing technical support, namely, troubleshooting customer problems with scientific measuring apparatus and instruments, namely substrate chips used in the measurement of biopolymers and biological samples; providing technical support, namely troubleshooting customer problems with hardware and software for analyzing images used for analysis of biopolymers and biological samples

Filing History

CANCELLED SEC. 8 (6-YR)
May 6, 2011 C8..
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 4, 2009 ASGN
REVIEW OF CORRESPONDENCE COMPLETE
Sep 18, 2006 CORV
PAPER RECEIVED
Sep 8, 2006 MAIL
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 2, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Oct 5, 2004 R.PR
PUBLISHED FOR OPPOSITION
Jul 13, 2004 PUBO
NOTICE OF PUBLICATION
Jun 23, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2004 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2003 CRFA
FAX RECEIVED
Sep 17, 2003 FAXX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2003 TCCA
CASE FILE IN TICRS
Aug 5, 2003 CFIT
LETTER OF SUSPENSION MAILED
May 20, 2002 CNSL
PAPER RECEIVED
Mar 22, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2002 CRFA
NON-FINAL ACTION MAILED
Sep 21, 2001 CNRT
ASSIGNED TO EXAMINER
Sep 7, 2001 DOCK